OP Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
OP Asset Management's VRTX Position: Q2 2026 in Review
OP Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 8.6% in Q2 2026, buying an estimated $1M and bringing the position to 28,450 shares worth $14.1M. The position accounts for 0.15% of the portfolio, ranked #112.
OP Asset Management first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- OP Asset Management held 28,450 shares of Vertex Pharmaceuticals worth $14.1M as of Q2 2026.
- OP Asset Management bought 2,261 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1M.
- Vertex Pharmaceuticals made up 0.15% of OP Asset Management's portfolio in Q2 2026, its #112 holding.
- OP Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.